Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets

被引:7
|
作者
Yeolekar, Leena R. [1 ]
Guilfoyle, Kate [2 ]
Ganguly, Milan [1 ]
Tyagi, Parikshit [1 ]
Stittelaar, Koert J. [2 ]
van Amerongen, Geert [2 ]
Dhere, Rajeev M. [1 ]
BerlandaScorza, Francesco [3 ]
Mahmood, Kutub [3 ]
机构
[1] India Private Ltd, Serum Inst, 212-2 Off Soli Poonawalla Rd, Pune 411028, Maharashtra, India
[2] Viroclin Biosci BV, Viroclin Xplore, Nistelrooise Baan 3, NL-5374 RE Schaijk, Netherlands
[3] PATH, 2201 Westlake Ave, Seattle, WA 98121 USA
关键词
MDCK; Ferret; Live attenuated influenza vaccine; A/Leningrad/134/17/57; H5N1; H7N9; VIRUS; SAFETY; MOUSE; CULTURE; MODELS;
D O I
10.1016/j.vaccine.2020.07.043
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During a pandemic, the availability of specific pathogen free chicken eggs is a major bottleneck for upscaling response to the demand for influenza vaccine. This has led us to explore the use of Madin-Darby Canine Kidney (MDCK) cells for the manufacture of live attenuated influenza vaccine (LAIV) that provides production flexibility and speed. The present study reports the comparison of the immunogenicity and efficacy of two MDCK-based LAIVs against two egg-based LAIVs prepared from the same pandemic potential strains of H5 and H7 subtypes after a single dose of the vaccine followed by a challenge with a homologous wild type strain. The vaccine strains have been generated by classical method of reassortment using the A/Leningrad/134/17/57 master donor strain. Additionally, a prime-boost regimen of the MDCK-based vaccine followed by a challenge with a homologous wild type strain for H5 and H7 immunized ferrets and also a heterologous wild type strain for the H5 immunized animals was studied. No difference in the hemagglutination inhibition and virus neutralization antibody titers against the homologous virus was observed following a single dose of either egg-based or MDCK-based H5 and H7 LAIV vaccine. A second dose of MDCK-based vaccine significantly boosted antibody titers in the vaccinated animals. Both a single dose or two doses of LAIV provided complete protection from lower respiratory tract infection and resulted in a significant reduction in the virus titers recovered from the throat, nasal turbinates and lungs after challenge with the homologous wild type strain. Protection from a challenge with a heterologous strain of H5 was also observed after two doses of the MDCK-based LAIVs. This data strongly supports the use of MDCK as a substrate for the manufacture of LAIV which ensures reliable quality, safety, production flexibility, speed and breadth of protection, features that are highly critical during a pandemic. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6280 / 6290
页数:11
相关论文
共 50 条
  • [1] Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans
    Couch, Robert B.
    Decker, William K.
    Utama, Budi
    Atmar, Robert L.
    Nino, Diane
    Feng, Jing Qi
    Halpert, Matthew M.
    Air, Gillian M.
    [J]. PLOS ONE, 2012, 7 (12):
  • [2] Role of the Hemagglutinin Residue 227 in Immunogenicity of H5 and H7 Subtype Avian Influenza Vaccines in Chickens
    Hu, Zenglei
    Shi, Lei
    Zhao, Jiangyan
    Gu, Han
    Hu, Jiao
    Wang, Xiaoquan
    Liu, Xiaowen
    Hu, Shunlin
    Gu, Min
    Cao, Yongzhong
    Liu, Xiufan
    [J]. AVIAN DISEASES, 2020, 64 (04) : 445 - 450
  • [3] Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018
    Bruxvoort, Katia J.
    Luo, Yi
    Ackerson, Bradley
    Tanenbaum, Hilary C.
    Sy, Lina S.
    Gandhi, Ashesh
    Tseng, Hung Fu
    [J]. VACCINE, 2019, 37 (39) : 5807 - 5811
  • [4] Incidence of contamination of live bird markets in Bangladesh with influenza A virus and subtypes H5, H7 and H9
    Biswas, P. K.
    Giasuddin, M.
    Chowdhury, P.
    Barua, H.
    Debnath, N. C.
    Yamage, M.
    [J]. TRANSBOUNDARY AND EMERGING DISEASES, 2018, 65 (03) : 687 - 695
  • [5] Active surveillance in poultry in Poland for avian influenza subtypes H5 and H7
    Pikula, Anna
    Smietanka, Krzysztof
    Lisowska, Anna
    Minta, Zenon
    [J]. ACTA BIOCHIMICA POLONICA, 2014, 61 (03) : 459 - 463
  • [6] A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines
    Zhao, Hui
    Xu, Kangwei
    Jiang, Zheng
    Shao, Ming
    Liu, Shuzhen
    Li, Xuguang
    Wang, Junzhi
    Li, Changgui
    [J]. PLOS ONE, 2018, 13 (11):
  • [7] A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults
    Williams, Katherine, V
    Zhai, Bo
    Alcorn, John F.
    Nowalk, Mary Patricia
    Levine, Min Z.
    Kim, Sara S.
    Flannery, Brendan
    Geffel, Krissy Moehling
    Merranko, Amanda Jaber
    Nagg, Jennifer P.
    Collins, Mark
    Susick, Michael
    Clarke, Karen S.
    Zimmerman, Richard K.
    Martin, Judith M.
    [J]. VACCINE, 2022, 40 (05) : 780 - 788
  • [8] Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes
    Crawford, J
    Wilkinson, B
    Vosnesensky, A
    Smith, G
    Garcia, M
    Stone, H
    Perdue, ML
    [J]. VACCINE, 1999, 17 (18) : 2265 - 2274
  • [9] A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in Children
    Williams, Katherine, V
    Li, Zhu-Nan
    Zhai, Bo
    Alcorn, John F.
    Nowalk, Mary Patricia
    Levine, Min Z.
    Kim, Sara S.
    Flannery, Brendan
    Geffel, Krissy Moehling
    Merranko, Amanda Jaber
    Collins, Mark
    Susick, Michael
    Clarke, Karen S.
    Zimmerman, Richard K.
    Martin, Judith M.
    [J]. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2023, 12 (06) : 342 - 352
  • [10] Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
    Kubota-Koketsu, Ritsuko
    Yunoki, Mikihiro
    Okuno, Yoshinobu
    Ikuta, Kazuyoshi
    [J]. BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 87 - 94